SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+16.38%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$478M
AUM Growth
+$478M
(+4.7%)
Cap. Flow
-$13.6M
Cap. Flow
% of AUM
-2.84%
Top 10 Holdings %
Top 10 Hldgs %
39.23%
Holding
111
New
20
Increased
19
Reduced
33
Closed
21
Top Buys
| 1 |
Centene
CNC
|
$13.9M |
| 2 |
Cigna
CI
|
$10.8M |
| 3 |
Merck
MRK
|
$9.64M |
| 4 |
Icon
ICLR
|
$9.33M |
| 5 |
GSK
GSK
|
$9.19M |
Top Sells
| 1 |
AstraZeneca
AZN
|
$13.1M |
| 2 |
Cencora
COR
|
$12.5M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
$12.3M |
| 4 |
Sanofi
SNY
|
$10.7M |
| 5 |
Amgen
AMGN
|
$9.2M |
Sector Composition
| 1 | Healthcare | 90.08% |
| 2 | Consumer Staples | 1.38% |
| 3 | Technology | 0.69% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VAPO
26
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $6.2M | 1.26% |
258,261
+180,554
| +232% | +$4.34M |
|
27
Kura Oncology
KURA
$732M
| $6.04M | 1.23% |
213,471
+81,188
| +61% | +$2.3M |
|
|
HZNP
28
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $5.96M | 1.21% |
64,801
-34,100
| -34% | -$3.14M |
|
29
Cross Country Healthcare
CCRN
$420M
| $5.41M | 1.1% |
433,244
-51,920
| -11% | -$648K |
|
|
AYLA
30
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
| $5.35M | 1.09% |
489,988
+333,333
| +213% | +$3.64M |
|
|
ASLN
31
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $4.85M | 0.99% |
1,448,508
+55,854
| +4% | +$187K |
|
|
RDUS
32
DELISTED
Radius Health, Inc.
RDUS
| $4.82M | 0.98% |
230,957
-62,200
| -21% | -$1.3M |
|
33
Ardelyx
ARDX
$1.57B
| $4.77M | 0.97% |
720,621
+31,300
| +5% | +$207K |
|
34
Novavax
NVAX
$1.2B
| $4.66M | 0.95% |
+25,700
| New | +$4.66M |
|
35
Emergent Biosolutions
EBS
$418M
| $4.65M | 0.94% |
+50,000
| New | +$4.65M |
|
36
Salarius Pharmaceuticals
SLRX
$2.45M
| $4.62M | 0.94% |
3,118,696
+1,461,454
| +88% | +$2.17M |
|
|
SYNH
37
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $4.55M | 0.92% |
60,025
-4,975
| -8% | -$377K |
|
38
Vertex Pharmaceuticals
VRTX
$102B
| $4.53M | 0.92% |
21,067
-5,133
| -20% | -$1.1M |
|
|
NTUS
39
DELISTED
Natus Medical Inc
NTUS
| $4.34M | 0.88% |
169,454
-17,379
| -9% | -$445K |
|
|
AFMD
40
DELISTED
Affimed
AFMD
| $4.34M | 0.88% |
+548,044
| New | +$4.34M |
|
41
MacroGenics
MGNX
$121M
| $4.14M | 0.84% |
+130,000
| New | +$4.14M |
|
42
Moleculin Biotech
MBRX
$11.3M
| $3.93M | 0.8% |
+963,000
| New | +$3.93M |
|
|
CNST
43
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $3.89M | 0.79% |
166,186
+73,686
| +80% | +$1.72M |
|
44
Viking Therapeutics
VKTX
$3.02B
| $3.6M | 0.73% |
569,780
-40,000
| -7% | -$253K |
|
45
Cellectar Biosciences
CLRB
$15.3M
| $3.52M | 0.72% |
2,188,058
-143,065
| -6% | -$230K |
|
46
Precision BioSciences
DTIL
$59.5M
| $3.41M | 0.69% |
329,369
+11,725
| +4% | +$121K |
|
47
ASGN Inc
ASGN
$2.35B
| $3.3M | 0.67% |
34,577
-28,500
| -45% | -$2.72M |
|
48
Syndax Pharmaceuticals
SNDX
$1.39B
| $3.27M | 0.66% |
146,142
-24,000
| -14% | -$537K |
|
49
Spyre Therapeutics
SYRE
$1.02B
| $3.19M | 0.65% |
402,653
+211,549
| +111% | +$1.68M |
|
50
Gyre Therapeutics
GYRE
$734M
| $3.14M | 0.64% |
623,892
+435,178
| +231% | +$2.19M |
|